PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Bronchial Spasm D001986 18 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Body Weight D001835 333 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Blister D001768 16 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Astrocytoma D001254 15 associated lipids
Asthma D001249 52 associated lipids
Ascariasis D001196 3 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Ishimura M et al. Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea. 2006 Allergol Int pmid:17130683
Mazid MA et al. Endogenous 15-deoxy-Delta(12,14)-prostaglandin J(2) synthesized by adipocytes during maturation phase contributes to upregulation of fat storage. 2006 FEBS Lett. pmid:17150216
Rousseaux C and Desreumaux P [The peroxisome-proliferator-activated gamma receptor and chronic inflammatory bowel disease (PPARgamma and IBD)]. 2006 J. Soc. Biol. pmid:17151549
Kang DS et al. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism. 2006 Toxicol. Appl. Pharmacol. pmid:16890972
Nakata S et al. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis. 2006 Mol. Cancer Ther. pmid:16891469
Wang XS and Lau HY Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells. 2006 Clin. Exp. Pharmacol. Physiol. pmid:16895550
Zhang A et al. Prostaglandin D2 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in MDCK cells. 2006 Am. J. Physiol. Renal Physiol. pmid:16896186
Chaffer CL et al. PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma. 2006 BMC Cancer pmid:16519808
Pérez S et al. The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes. 2006 Biochim. Biophys. Acta pmid:16545597
Wise H Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells. 2006 Eur. J. Pharmacol. pmid:16545798
Wang XS et al. Functional characterization of human mast cells cultured from adult peripheral blood. 2006 Int. Immunopharmacol. pmid:16546715
Sawai H et al. Activation of peroxisome proliferator-activated receptor-gamma decreases pancreatic cancer cell invasion through modulation of the plasminogen activator system. 2006 Mol. Cancer Res. pmid:16547153
Ogburn KD et al. Prostaglandin J2 reduces catechol-O-methyltransferase activity and enhances dopamine toxicity in neuronal cells. 2006 Neurobiol. Dis. pmid:16406650
Honma Y et al. Effects of indomethacin and dexamethasone on mechanical scratching-induced cutaneous barrier disruption in mice. 2006 Exp. Dermatol. pmid:16761958
El Mezayen R et al. Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation. 2006 Immunol. Lett. pmid:16762422
Lin TN et al. 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury. 2006 Arterioscler. Thromb. Vasc. Biol. pmid:16385084
Kobayashi M et al. ATM activation by a sulfhydryl-reactive inflammatory cyclopentenone prostaglandin. 2006 Genes Cells pmid:16824197
Ding J et al. Cyclooxygenase isozymes are expressed in human myeloma cells but not involved in anti-proliferative effect of cyclooxygenase inhibitors. 2006 Mol. Carcinog. pmid:16385588
Ogburn KD and Figueiredo-Pereira ME Cytoskeleton/endoplasmic reticulum collapse induced by prostaglandin J2 parallels centrosomal deposition of ubiquitinated protein aggregates. 2006 J. Biol. Chem. pmid:16774923
Landar A et al. Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. 2006 Am. J. Physiol. Heart Circ. Physiol. pmid:16387790
Zhang M et al. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. 2006 Int. Immunopharmacol. pmid:16782535
Shimizu T et al. A role of PPAR-gamma in androstenediol-mediated salutary effects on cardiac function following trauma-hemorrhage. 2006 Ann. Surg. pmid:16794398
Chen Y et al. Effects of PPARgamma agonists on cell survival and focal adhesions in a Chinese thyroid carcinoma cell line. 2006 J. Cell. Biochem. pmid:16795079
Yucel-Lindberg T et al. Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts. 2006 Cell. Signal. pmid:16766159
Relic B et al. Peroxisome proliferator-activated receptor-gamma1 is dephosphorylated and degraded during BAY 11-7085-induced synovial fibroblast apoptosis. 2006 J. Biol. Chem. pmid:16766531
Sugimoto M et al. Role of COX-1 and COX-2 on skin PGs biosynthesis by mechanical scratching in mice. 2006 Prostaglandins Leukot. Essent. Fatty Acids pmid:16815697
Schwartz MS et al. Determination of a prostaglandin D2 antagonist and its acyl glucuronide metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometric detection--a lack of MS/MS selectivity between a glucuronide conjugate and a phase I metabolite. 2006 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:16716772
Na HK and Surh YJ Transcriptional regulation via cysteine thiol modification: a novel molecular strategy for chemoprevention and cytoprotection. 2006 Mol. Carcinog. pmid:16673384
Brazís P et al. Dermal microdialysis in the dog: in vivo assessment of the effect of cyclosporin A on cutaneous histamine and prostaglandin D2 release. 2006 Vet. Dermatol. pmid:16674731
Hickson-Bick DL et al. The response of neonatal rat ventricular myocytes to lipopolysaccharide-induced stress. 2006 Shock pmid:16680021
Son MJ et al. Naturally occurring biflavonoid, ochnaflavone, inhibits cyclooxygenases-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. 2006 Arch. Pharm. Res. pmid:16681032
Bellows CF et al. Modulation of macrophage nitric oxide production by prostaglandin D2. 2006 J. Surg. Res. pmid:16289592
Helliwell RJ et al. Gestational age-dependent up-regulation of prostaglandin D synthase (PGDS) and production of PGDS-derived antiinflammatory prostaglandins in human placenta. 2006 J. Clin. Endocrinol. Metab. pmid:16291703
Grill M et al. Systemic inflammation induces COX-2 mediated prostaglandin D2 biosynthesis in mice spinal cord. 2006 Neuropharmacology pmid:16182321
Stamatakis K et al. Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton. 2006 J. Am. Soc. Nephrol. pmid:16291835
Zhao X et al. 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. 2006 J. Cereb. Blood Flow Metab. pmid:16208315
Landar A et al. Induction of the permeability transition and cytochrome c release by 15-deoxy-Delta12,14-prostaglandin J2 in mitochondria. 2006 Biochem. J. pmid:16268779
Cesario RM et al. Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer. 2006 Cancer Lett. pmid:16271436
Ye P et al. [The role of peroxisome proliferator-activated receptor gamma in proliferation of cardiac non myocytes]. 2006 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21162229
Garg TK and Chang JY Methylmercury causes oxidative stress and cytotoxicity in microglia: attenuation by 15-deoxy-delta 12, 14-prostaglandin J2. 2006 J. Neuroimmunol. pmid:16225932
Shiraki T et al. Spectroscopic analyses of the binding kinetics of 15d-PGJ2 to the PPARgamma ligand-binding domain by multi-wavelength global fitting. 2006 Biochem. J. pmid:16236024
Benkirane K et al. PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1. 2006 Am. J. Physiol. Heart Circ. Physiol. pmid:16155101
Millán O et al. Potentiation of tumor formation by topical administration of 15-deoxy-delta12,14-prostaglandin J2 in a model of skin carcinogenesis. 2006 Carcinogenesis pmid:16113051
Tanaka H et al. Polymer-assisted solution-phase synthesis and neurite-outgrowth-promoting activity of 15-deoxy-delta(12,14)-PGJ2 derivatives. 2006 Chem Asian J pmid:17441107
Peeraully MR et al. Prostaglandin D2 and J2-series (PGJ2, Delta12-PGJ2) prostaglandins stimulate IL-6 and MCP-1, but inhibit leptin, expression and secretion by 3T3-L1 adipocytes. 2006 Pflugers Arch. pmid:16924534
Eucker J et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma. 2006 Anticancer Drugs pmid:16926626
Satoh T et al. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. 2006 J. Immunol. pmid:16888024
Sugimoto M et al. COX-1 inhibition enhances scratching behaviour in NC/Nga mice with atopic dermatitis. 2006 Exp. Dermatol. pmid:16842596
Quinkler M et al. Depot-specific prostaglandin synthesis in human adipose tissue: a novel possible mechanism of adipogenesis. 2006 Gene pmid:16842938
Raikwar HP et al. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2. 2006 J. Neuroimmunol. pmid:16844232
Willermain F et al. 15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism. 2006 Prostaglandins Other Lipid Mediat. pmid:16939878
Lim HJ et al. PPARgamma activation induces CD36 expression and stimulates foam cell like changes in rVSMCs. 2006 Prostaglandins Other Lipid Mediat. pmid:16939881
Chiba T et al. Prostaglandin D2 induces IL-8 and GM-CSF by bronchial epithelial cells in a CRTH2-independent pathway. 2006 Int. Arch. Allergy Immunol. pmid:16940740
Yu X et al. Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12,14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase. 2006 J. Biol. Chem. pmid:16857669
Chen ZH et al. Induction of adaptive response and enhancement of PC12 cell tolerance by 7-hydroxycholesterol and 15-deoxy-delta(12,14)-prostaglandin J2 through up-regulation of cellular glutathione via different mechanisms. 2006 J. Biol. Chem. pmid:16565077
Horiguchi T et al. Cyclooxygenase-2 mediates the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. 2006 Neuroscience pmid:16567054
Siddhivarn C et al. Prostaglandin D2 pathway and peroxisome proliferator-activated receptor gamma-1 expression are induced by mechanical loading in an osteoblastic cell line. 2006 J. Periodont. Res. pmid:16499711
Coyle AT and Kinsella BT Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells. 2006 Biochem. Pharmacol. pmid:16499875
Makino N et al. Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia. 2006 Cell Biochem. Biophys. pmid:16456235
Figarella K et al. Prostaglandin-induced programmed cell death in Trypanosoma brucei involves oxidative stress. 2006 Cell Death Differ. pmid:16456581
Takai S et al. Prostaglandin D2 induces the phosphorylation of HSP27 in osteoblasts: function of the MAP kinase superfamily. 2006 Prostaglandins Leukot. Essent. Fatty Acids pmid:16876988
Piraino G et al. Synergistic effect of peroxisome proliferator activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages. 2006 Shock pmid:16878022
Moulin D et al. Effect of peroxisome proliferator activated receptor (PPAR)gamma agonists on prostaglandins cascade in joint cells. 2006 Biorheology pmid:16912428
Yeh CH et al. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators. 2006 Shock pmid:16912651
Ye F et al. Quantitative characterization of 15-deoxy-delta(12,14)-prostaglandin J2 in regulating EGFPSmad2 translocation in CHO cells through PPARgamma/TGFbeta/Smad2 pathway. 2006 Cell. Physiol. Biochem. pmid:16914899
Lee JJ et al. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization. 2006 Vascul. Pharmacol. pmid:16916624
Ulven T and Kostenis E Targeting the prostaglandin D2 receptors DP and CRTH2 for treatment of inflammation. 2006 Curr Top Med Chem pmid:16918458
Theiner G et al. The mast cell mediator PGD2 suppresses IL-12 release by dendritic cells leading to Th2 polarized immune responses in vivo. 2006 Immunobiology pmid:16920486
Urade Y and Mohri I [Sleep and brain function]. 2006 No To Hattatsu pmid:16986732
Kim EH and Surh YJ 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. 2006 Biochem. Pharmacol. pmid:16987499
Diaz BL et al. Group V secretory phospholipase A2 amplifies the induction of cyclooxygenase 2 and delayed prostaglandin D2 generation in mouse bone marrow culture-derived mast cells in a strain-dependent manner. 2006 Biochim. Biophys. Acta pmid:17064958
Calabrò P et al. Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects. 2005 Nov-Dec J. Vasc. Res. pmid:16155367
Marchini C et al. Aspirin modulates LPS-induced nitric oxide release in rat glial cells. 2005 Jun 10-17 Neurosci. Lett. pmid:15882795
Masuko-Hongo K [Role of prostaglandins in rheumatoid arthritis]. 2005 Nippon Rinsho pmid:15799333
Yuan J et al. Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma. 2005 Urology pmid:15780399
Chou YH et al. The possible role of heat shock factor-1 in the negative regulation of heme oxygenase-1. 2005 Int. J. Biochem. Cell Biol. pmid:15618017
Farrajota K et al. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. 2005 Arthritis Rheum. pmid:15641079
Liu JJ et al. Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro. 2005 Ann. Oncol. pmid:15642706
Iwata C et al. Augmentation of lipogenesis by 15-deoxy-Delta12,14-prostaglandin J2 in hamster sebaceous glands: identification of cytochrome P-450-mediated 15-deoxy-Delta12,14-prostaglandin J2 production. 2005 J. Invest. Dermatol. pmid:16297182
Thomas RK et al. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies. 2005 Clin. Cancer Res. pmid:16299251
Sugimoto M et al. Increased scratching counts depend on a decrease in ability of cutaneous prostaglandin D2 biosynthesis in NC/Nga mice with atopic dermatitis. 2005 Exp. Dermatol. pmid:16274457
Shiraki T et al. [Activation mechanism of PPARgamma by its endogenous ligands]. 2005 Tanpakushitsu Kakusan Koso pmid:16277244
Mouihate A et al. Fever suppression in near-term pregnant rats is dissociated from LPS-activated signaling pathways. 2005 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:16037126
Nakae K et al. Functional role of prostacyclin receptor in rat dorsal root ganglion neurons. 2005 Neurosci. Lett. pmid:16039053
Gelir E et al. Effect of rapid-eye-movement sleep deprivation on rat hypothalamic prostaglandins. 2005 Prostaglandins Leukot. Essent. Fatty Acids pmid:16039105
Masini E et al. Reduction of antigen-induced respiratory abnormalities and airway inflammation in sensitized guinea pigs by a superoxide dismutase mimetic. 2005 Free Radic. Biol. Med. pmid:16043023
Stahlschmidt J et al. Urothelial differentiation in chronically urine-deprived bladders of patients with end-stage renal disease. 2005 Kidney Int. pmid:16105033
Malki S et al. Prostaglandin D2 induces nuclear import of the sex-determining factor SOX9 via its cAMP-PKA phosphorylation. 2005 EMBO J. pmid:15889150
Wang Z and Figueiredo-Pereira ME Inhibition of sequestosome 1/p62 up-regulation prevents aggregation of ubiquitinated proteins induced by prostaglandin J2 without reducing its neurotoxicity. 2005 Mol. Cell. Neurosci. pmid:15911346
Ishida A et al. Characterization of cAMP-dependent proteolysis of GATA-6. 2005 Biochem. Biophys. Res. Commun. pmid:15913546
Hennersdorf F et al. Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation. 2005 Cell Res. pmid:15916720
Hosoya T et al. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. 2005 J. Biol. Chem. pmid:15917255
Pataki I et al. In vivo effects of isatin on rat platelet eicosanoids. 2005 Platelets pmid:15763895
Ibabe A et al. Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes. 2005 Toxicol In Vitro pmid:15964169
Pande V and Ramos MJ Molecular recognition of 15-deoxy-delta(12,14)-prostaglandin J2 by nuclear factor-kappa B and other cellular proteins. 2005 Bioorg. Med. Chem. Lett. pmid:16006125
Eggler AL et al. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:16006525
Matsuzaki Y et al. 15-deoxy-Delta12, 14-prostaglandin J2 activates the expression of p15INK4b gene, a cyclin-dependent kinase inhibitor. 2005 Int. J. Oncol. pmid:16010433
Maurin AC et al. Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids. 2005 Calcif. Tissue Int. pmid:15868283
Lindström TM and Bennett PR 15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications. 2005 J. Clin. Endocrinol. Metab. pmid:15755849
Takashima T et al. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma. 2005 Oncol. Rep. pmid:15756430